Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Observatory
  • Newsletter
  • Methodology
  • Origins
  • Vocab
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
  1. Home
  2. Research
  3. Helix
  4. Spatial Transcriptomics AI Mapping

Spatial Transcriptomics AI Mapping

Algorithms reconstructing 3D gene expression maps from tissue sections.
Back to HelixView interactive version

Spatial transcriptomics AI mapping uses deep learning pipelines that merge high-resolution histological imaging with RNA sequencing data to visualize gene expression patterns within the physical architecture of tissues, creating three-dimensional maps that show where specific genes are expressed in relation to tissue structure. This software enables researchers to map the 'cellular sociology' of complex tissue environments like tumor microenvironments or aging tissues, identifying localized drivers of processes like cellular senescence that bulk sequencing (which averages across entire samples) would miss, providing insights into how spatial organization affects biological processes.

This innovation addresses the limitation of traditional transcriptomics, where gene expression is measured in bulk samples without spatial context, losing important information about how location and cellular interactions affect gene expression. By preserving spatial information, these systems enable understanding of how tissue architecture and cellular neighborhoods influence biological processes. Companies like 10x Genomics, NanoString, and research institutions are developing these technologies.

The technology is particularly valuable for understanding complex tissues like tumors or aging organs, where spatial organization is critical to function and disease. As the technology improves, it could become standard for many types of tissue analysis. However, ensuring accuracy, managing data complexity, and integrating with existing workflows remain challenges. The technology represents an important advance in understanding tissue biology, but requires continued development to achieve the resolution and accuracy needed for all applications. Success could provide new insights into disease mechanisms and tissue biology, enabling better understanding of complex biological processes and potentially leading to new therapeutic approaches.

TRL
6/9Demonstrated
Impact
4/5
Investment
5/5
Category
Software

Related Organizations

10x Genomics logo
10x Genomics

United States · Company

95%

Market leader in spatial biology with the Visium and Xenium platforms for mapping gene expression in tissue context.

Developer
Broad Institute of MIT and Harvard logo
Broad Institute of MIT and Harvard

United States · Research Lab

95%

A biomedical and genomic research center that holds key patents for the use of CRISPR-Cas9 in eukaryotic cells.

Researcher
NanoString Technologies

United States · Company

95%

Developer of the GeoMx Digital Spatial Profiler and CosMx Spatial Molecular Imager; acquired by Bruker.

Developer
Owkin logo
Owkin

France · Startup

90%

A biotech company that uses federated learning to train AI models on distributed patient data without the data leaving hospitals.

Developer
Resolve Biosciences

Germany · Startup

90%

Developers of the Molecular Cartography platform for high-resolution spatial transcriptomics.

Developer
Vizgen

United States · Startup

90%

Commercializes MERSCOPE, a platform for MERFISH (Multiplexed Error-Robust Fluorescence in situ Hybridization) spatial transcriptomics.

Developer

Akoya Biosciences

United States · Company

85%

Provides spatial biology solutions (PhenoCycler, PhenoImager) for high-parameter tissue analysis.

Developer
Curio Bioscience

United States · Startup

85%

Commercializes Slide-seq technology (Curio Seeker) for high-resolution spatial transcriptomics.

Developer
European Molecular Biology Laboratory (EMBL)

Germany · Research Lab

85%

Intergovernmental research organization developing computational methods (e.g., MOFA, spatial analysis tools) for multi-omics.

Researcher
Standard BioTools

United States · Company

80%

Offers the Hyperion XTi Imaging System for spatial biology and high-plex imaging.

Developer

Supporting Evidence

Evidence data is not available for this technology yet.

Connections

Software
Software
AI-Accelerated Protein & Cell Engineering

Generative models for de novo protein design and cell behavior prediction.

TRL
6/9
Impact
5/5
Investment
5/5

Book a research session

Bring this signal into a focused decision sprint with analyst-led framing and synthesis.
Research Sessions